Journal Article Summary
The article examines the relationship between combined oral contraceptives (COCs) and the risk of venous thrombosis (VT), which includes conditions like deep vein thrombosis and pulmonary embolism. Understanding this risk is crucial as COCs are widely used for contraception, and while they are effective, they can also lead to serious health complications. The study aims to provide a comprehensive comparison of the VT risk associated with various COCs, considering different estrogen doses and types of progestagens.
To conduct the study, researchers reviewed numerous publications and selected 25 studies that included healthy women using COCs and reported on VT outcomes. They found that using COCs significantly increased the risk of venous thrombosis compared to non-users, with a relative risk of 3.5. Among the different formulations, those containing 30-35 μg of ethinylestradiol combined with certain progestagens (gestodene, desogestrel, cyproterone acetate, or drospirenone) posed a higher risk—about 50-80% more than those with levonorgestrel. Additionally, a dose-related effect was noted, indicating that higher doses of ethinylestradiol were linked to increased thrombosis risk.
The study has some limitations, including the potential for variability in the quality of the included studies and the fact that it focused only on healthy women. Patients should be aware that while the risk of venous thrombosis is relatively low, it is still a serious concern when considering COCs. It is important for individuals to discuss their contraceptive options with a healthcare professional, especially regarding the type of pill and its associated risks, to ensure they choose the safest option for their health.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- de Bastos Marcos, Stegeman Bernardine H., Rosendaal Frits R., Van Hylckama Vlieg Astrid, Helmerhorst Frans M, Stijnen Theo, Dekkers Olaf M. Combined oral contraceptives: venous thrombosis. The Cochrane Database of Systematic Reviews 2014. DOI: 10.1002/14651858.CD010813.pub2. PMID: 24590565. PMCID: PMC10637279.
Featured Pill Pals Product
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) --- Perrigo --- Over The Counter
OPill (O-Pill) Norgestrel Tablets 0.075 mg Daily Oral Contraceptive (Birth Control) — Perrigo — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
